Patents by Inventor Jerome T. Hartlaub

Jerome T. Hartlaub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7776031
    Abstract: An implantable drug infusion pump for delivering drug therapy to a patient and which also permits a patient to deliver or self-administer an additional bolus, reduces the likelihood of over dosage or under dosage by drug dosage characteristic limitations programmed into a microprocessor memory. The dose limits define the maximum and minimum amount of drug to be delivered per unit time or otherwise, reducing the likelihood that a patient may inadvertently or deliberately interfere with a treatment regimen.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: August 17, 2010
    Assignee: Medtronic, Inc.
    Inventors: Jerome T. Hartlaub, Duane L. Bourget
  • Publication number: 20100145271
    Abstract: An implantable drug infusion pump for delivering drug therapy is made more reliable and its performance improved by monitoring drug pump temperature. Monitoring pump temperature can also provide for temperature-related drug therapy modification. A pump temperature sensor is read by the infusion pump's microprocessor. Pump temperature data is stored in pump memory for later access by a remote controller. A simple thermistor or semiconductor temperature sensor can provide fast and reliable temperature monitoring of the pump and/or of a patient by reading the temperature sensor's value and calculating a temperature therefrom.
    Type: Application
    Filed: February 15, 2010
    Publication date: June 10, 2010
    Applicant: Medtronic, Inc.
    Inventors: Jerome T. Hartlaub, James M. Olsen
  • Patent number: 7658737
    Abstract: An implantable drug infusion pump for delivering drug therapy is made more reliable and its performance improved by monitoring drug pump temperature. Monitoring pump temperature can also provide for temperature-related drug therapy modification. A pump temperature sensor is read by the infusion pump's microprocessor. Pump temperature data is stored in pump memory for later access by a remote controller. A simple thermistor or semiconductor temperature sensor can provide fast and reliable temperature monitoring of the pump and/or of a patient by reading the temperature sensor's value and calculating a temperature therefrom.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: February 9, 2010
    Assignee: Medtronic, Inc.
    Inventors: Jerome T. Hartlaub, James M. Olsen
  • Patent number: 7505869
    Abstract: Disclosed is a method and apparatus for determining whether an implantable drug delivery device is conforming to the performance requirements of the device or the needs of the patient. The system includes an implantable drug delivery device having stored therein at least one drug, a nonconformance monitor module monitoring pump parameters, an external programmer in telemetric communication with the implantable drug delivery device and having a nonconformance management module for determining whether the device is conforming to performance requirements, and to determine what action should be taken if non-conformance is determined. If the nonconformance management module identifies nonconformance, it determines what action should be taken for the particular non-conformance. The nonconformance management module will either invoke a pump programming change, or schedule and appointment or notify the patient that a non-programming change should be made.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: March 17, 2009
    Assignee: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Patent number: 7415384
    Abstract: Disclosed is a method and apparatus for automatically adjusting drug infusion rate to optimize treatment therapy. The implantable medical device can communicate with a database or algorithm controlled by a caregiver or physician. Thus, the caregiver may request a therapy change (e.g., infusion rate versus time, pump clock settings, etc.) or a therapy management module may automatically activate the therapy change at some future time for convenience, or for technical or clinical reasons.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: August 19, 2008
    Inventor: Jerome T. Hartlaub
  • Patent number: 7072802
    Abstract: Disclosed is a method and apparatus for automatically adjusting drug infusion rate to optimize treatment therapy. The implantable medical device can communicate with a database or algorithm controlled by a caregiver or physician. Thus, the caregiver may request a therapy change (e.g., infusion rate versus time, pump clock settings, etc.) or a therapy management module may automatically activate the therapy change at some future time for convenience, or for technical or clinical reasons.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: July 4, 2006
    Assignee: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Patent number: 7054782
    Abstract: Disclosed is a method and apparatus for determining whether an implantable drug delivery device is conforming to the performance requirements of the device or the needs of the patient. The system includes an implantable drug delivery device having stored therein at least one drug, a nonconformance monitor module monitoring pump parameters, an external programmer in telemetric communication with the implantable drug delivery device and having a nonconformance management module for determining whether the the device is conforming to performance requirements, and to determine what action should be taken if non-conformance is determined. If the nonconformance management module identifies nonconformance, it determines what action should be taken for the particular non-conformance. The nonconformance management module will either invoke a pump programming change, or schedule and appointment or notify the patient that a non-programming change should be made.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: May 30, 2006
    Assignee: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Patent number: 6799149
    Abstract: Disclosed is a method and apparatus for automatically adjusting drug infusion rate to optimize treatment therapy. The implantable medical device communicates with a database or algorithm controlled by a caregiver or physician. Thus, the caregiver may request a therapy change (e.g., infusion rate versus time, pump clock settings, etc.) or a therapy management module may automatically activate the therapy change at some future time for convenience, or for technical or clinical reasons.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: September 28, 2004
    Assignee: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Patent number: 6796956
    Abstract: An implantable drug infusion pump for delivering drug therapy to a patient and which also permits a patient to deliver or self-administer an additional bolus, reduces the likelihood of over dosage or under dosage by drug dosage characteristic limitations programmed into a microprocessor memory. The dose limits define the maximum and minimum amount of drug to be delivered per unit time or otherwise, reducing the likelihood that a patient may inadvertently or deliberately interfere with a treatment regimen.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: September 28, 2004
    Assignee: Medtronic, Inc.
    Inventors: Jerome T Hartlaub, Duane L Bourget
  • Patent number: 6450172
    Abstract: Methods and apparatus for communication of implantable medical device (IMD) information, including interrogation of programmed parameter values, operating modes and conditions of operation, confirmation of programmed changes thereof, interrogation of data stored in the IMD, and patient warnings or other messages by RF transmission of audible sounds generated by the IMD are disclosed. The IMD includes an RF transmitter that broadcasts or transmits audible sounds including voiced statements or musical tones stored in analog memory correlated to a programming or interrogation operating algorithm or to a warning trigger event. The broadcast radio signal is received, and the audible sounds are demodulated and reproduced by a radio receiver as voiced statements or musical tones that convey human understandable messages comprising IMD information generated during programming and interrogation sessions and warnings or status messages to the patient at other times.
    Type: Grant
    Filed: January 25, 2000
    Date of Patent: September 17, 2002
    Assignee: Medtronic, Inc.
    Inventors: Jerome T. Hartlaub, David L. Thompson, Daniel R. Greeninger
  • Publication number: 20020087116
    Abstract: Disclosed is a method and apparatus for scheduling a patient for an appointment with a caregiver, for example, when an implantable device needs to be refilled for drug. The date scheduling of a patient visit to a clinic is automatically arranged and communicated to caregivers and the patient based on a scheduling algorithm. The system includes an implantable drug delivery device having stored therein at least one drug, a drug monitor module monitoring drug usage and drug levels, an external device in telemetric communication with the implantable drug delivery device and having a drug scheduling module for determining whether patient should visit with his/her caregiver. If it is determined that the patient should visit his/her caregiver, the external device will contact various entities involved in the healthcare management of the patient to schedule an appointment. The various entities include, for example, an insurance provider, a pharmacy, a hospital, a caregiver, a physician, and a device manufacturer.
    Type: Application
    Filed: October 31, 2001
    Publication date: July 4, 2002
    Applicant: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Publication number: 20020087114
    Abstract: Disclosed is a method and apparatus for automatically adjusting drug infusion rate to optimize treatment therapy. The implantable medical device communicates with a database or algorithm controlled by a caregiver or physician. Thus, the caregiver may request a therapy change (e.g., infusion rate versus time, pump clock settings, etc.) or a therapy management module may automatically activate the therapy change at some future time for convenience, or for technical or clinical reasons.
    Type: Application
    Filed: October 31, 2001
    Publication date: July 4, 2002
    Applicant: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Publication number: 20020087115
    Abstract: Disclosed is a method and apparatus for determining whether an implantable drug delivery device is conforming to the performance requirements of the device or the needs of the patient. The system includes an implantable drug delivery device having stored therein at least one drug, a nonconformance monitor module monitoring pump parameters, an external programmer in telemetric communication with the implantable drug delivery device and having a nonconformance management module for determining whether the the device is conforming to performance requirements, and to determine what action should be taken if non-conformance is determined. If the nonconformance management module identifies nonconformance, it determines what action should be taken for the particular non-conformance. The nonconformance management module will either invoke a pump programming change, or schedule and appointment or notify the patient that a non-programming change should be made.
    Type: Application
    Filed: October 31, 2001
    Publication date: July 4, 2002
    Applicant: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Publication number: 20020087113
    Abstract: Disclosed is a method and apparatus for determining whether an implantable device needs to be refilled for drug. The system includes an implantable drug delivery device having stored therein at least one drug, a drug monitor module monitoring drug usage and drug levels, an external programmer in telemetric communication with the implantable drug delivery device and having a drug management module for determining whether the drug should be replenished based upon the drug usage information from the drug monitoring module and various other parameters. If it is determined that the implanted device needs to be replenished, the external programmer will contact various entities involved in the healthcare management of the patient to schedule an appointment to refill the device. The various entities include, for example, an insurance provider, a pharmacy, a hospital, a caregiver, a physician, and a device manufacturer.
    Type: Application
    Filed: October 31, 2001
    Publication date: July 4, 2002
    Applicant: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Publication number: 20020042596
    Abstract: An implantable drug infusion pump for delivering drug therapy is made more reliable and its performance improved by monitoring drug pump temperature. Monitoring pump temperature can also provide for temperature-related drug therapy modification.
    Type: Application
    Filed: September 10, 2001
    Publication date: April 11, 2002
    Inventors: Jerome T. Hartlaub, James M. Olsen
  • Publication number: 20020042597
    Abstract: The invention provides implantable infusion systems, including apparatus and methods, for prolonged infusion of a carefully designed medicament composition to create and maintain a comprehensive microenvironment at a target area in a living body. The composition may include living cells to treat a particular disease and which deliver exogenous substances to maintain a microenvironment in the living body. The invention contemplates medicament compositions that include stem cells (neuro or otherwise), including homographs and allographs, adhesive peptides, substances which inhibit fiberblast growth, genetically modified cells which produce useful exogenous substances, nerve growth factor (NGF), previously harvested cells from a living body. In another aspect, the invention contemplates the replication of cells in a reservoir, for example, to keep cells alive in a dormant state until infusion.
    Type: Application
    Filed: November 8, 2001
    Publication date: April 11, 2002
    Applicant: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Patent number: 6370433
    Abstract: Methods and apparatus for communication of implantable medical device (IMD) information, including interrogation of programmed parameter values, operating modes and conditions of operation, confirmation of programmed changes thereof, interrogation of data stored in the IMD, and patient warnings or other messages by RF transmission of audible sounds generated by the IMD are disclosed. The IMD includes an RF transmitter that broadcasts or transmits audible sounds including voiced statements or musical tones stored in analog memory correlated to a programming or interrogation operating algorithm or to a warning trigger event. The broadcast radio signal is received, and the audible sounds are demodulated and reproduced by a radio receiver as voiced statements or musical is tones that convey human understandable messages comprising IMD information generated during programming and interrogation sessions and warnings or status messages to the patient at other times.
    Type: Grant
    Filed: January 25, 2000
    Date of Patent: April 9, 2002
    Assignee: Medtronic, Inc.
    Inventors: Jerome T. Hartlaub, David L. Thompson, Daniel R. Greeninger
  • Patent number: 6348050
    Abstract: The invention provides implantable infusion systems, including apparatus and methods, for prolonged infusion of a carefully designed medicament composition to create and maintain a comprehensive microenvironment at a target area in a living body. The composition may include living cells to treat a particular disease and which deliver exogenous substances to maintain a microenvironment in the living body. The invention contemplates medicament compositions that include stem cells (neuro or otherwise), including homographs and allographs, adhesive peptides, substances which inhibit fiberblast growth, genetically modified cells which produce useful exogenous substances, nerve growth factor (NGF), previously harvested cells from a living body. In another aspect, the invention contemplates the replication of cells in a reservoir, for example, to keep cells alive in a dormant state until infusion.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: February 19, 2002
    Assignee: Medtronic, Inc.
    Inventor: Jerome T. Hartlaub
  • Publication number: 20010037083
    Abstract: An implantable drug infusion pump for delivering drug therapy to a patient and which also permits a patient to deliver or self-administer an additional bolus, reduces the likelihood of over dosage or under dosage by drug dosage characteristic limitations programmed into a microprocessor memory. The dose limits define the maximum and minimum amount of drug to be delivered per unit time or otherwise, reducing the likelihood that a patient may inadvertently or deliberately interfere with a treatment regimen.
    Type: Application
    Filed: March 12, 2001
    Publication date: November 1, 2001
    Inventors: Jerome T. Hartlaub, Duane L. Bourget
  • Patent number: 6282450
    Abstract: In a medical treatment device implanted within the body of a patient, a system and method for organizing storage of the device's firmware in ROM, RAM, and EEPROM such that a ROM-based system is implemented initially using pointers stored in RAM, which RAM-based pointers point to ROM-based functions. When revisions to the functionality of the treatment device are desired, code is downlinked via an external programmer and telemetry to link to RAM, and one or more pointers, as appropriate, which pointers point to the downlinked code in RAM, are downlinked to RAM. In this manner, revisions to the firmware of an implanted medical treatment device can be downlinked to the device thereby eliminating the need to explant the device in certain circumstances. The amount of code placed in ROM is maximized, with only pointers to functions and new or revised code segments stored in RAM as needed.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: August 28, 2001
    Assignee: Medtronic, Inc.
    Inventors: Jerome T. Hartlaub, Earle T. Roberts, David C. Ullestad